表达Fim3的百日咳鲍特菌减毒活疫苗株BPZE1的构建与评价
为改进百日咳疫苗,研究者构建了同时产生Fim2和Fim3菌毛的BPZE1衍生株BPZE1f3。小鼠鼻内接种BPZE1f3可同时诱导抗Fim2和抗Fim3抗体,且对仅产Fim3的百日咳鲍特菌保护显著强于BPZE1,提示菌毛免疫应答贡献血清型特异性保护。
要点
- BPZE1f3可同时诱导抗Fim2和抗Fim3抗体,水平相近。
- BPZE1与BPZE1f3对Fim2、Fim2+Fim3或无菌毛菌株保护水平相同。
- BPZE1f3对仅产Fim3菌株的保护显著强于BPZE1。
核心结论
- 菌毛免疫应答有助于对百日咳鲍特菌感染的血清型特异性保护。
研究设计与样本
- 构建BPZE1衍生株BPZE1f3,并在小鼠中鼻内接种评价免疫原性与保护力。
主要发现
- BPZE1鼻内接种小鼠诱导抗Fim2抗体但不诱导抗Fim3抗体,BPZE1f3诱导抗Fim2和抗Fim3抗体且水平相近。
- 小鼠中BPZE1与BPZE1f3对仅产Fim2、同时产Fim2和Fim3或不产菌毛的临床分离株提供相同水平保护。
- BPZE1f3对仅产Fim3的百日咳鲍特菌保护显著强于BPZE1。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pertussis or whooping cough is currently the most prevalent vaccine-preventable childhood disease despite >85% global vaccination coverage. In recent years incidence has greatly increased in several high-income countries that have switched from the first-generation, whole-cell vaccine to the newer acellular vaccines, calling for improved vaccination strategies with better vaccines. We have developed a live attenuated pertussis vaccine candidate, called BPZE1, which is currently in clinical development. Unlike other pertussis vaccines, BPZE1 has been shown to provide strong protection against infection by the causative agent of pertussis, Bordetella pertussis, in non-human primates. BPZE1 is a derivative of the B. pertussis strain Tohama I, which produces serotype 2 (Fim2) but not serotype 3 fimbriae (Fim3). As immune responses to fimbriae are likely to contribute to protection, we constructed a BPZE1 derivative, called BPZE1f3, that produces both serotypes of fimbriae. Whereas nasal vaccination of mice with BPZE1 induced antibodies to Fim2 but not to Fim3, vaccination with BPZE1f3 elicited antibodies to both Fim2 and Fim3 at approximately the same level. In mice, both BPZE1 and BPZE1f3 provided equal levels of protection against clinical isolates that either produce Fim2 alone, both Fim2 and Fim3, or no fimbriae. However, vaccination with BPZE1f3 provided significantly stronger protection against Fim3-only producing B. pertussis than vaccination with BPZE1, indicating that immune responses to fimbriae contribute to serotype-specific protection against B. pertussis infection.
引用
- Debrie AS, Coutte L, Raze D, et al. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3. Vaccine. 2018. PMID: 29433898. doi:10.1016/j.vaccine.2018.02.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。